Dr. Berra Yazar-Klosinski

Dr. Berra Yazar-Klosinski is a highly experienced Chief Scientific Officer currently working at Lykos Therapeutics. With a background in biochemistry, biophysical methods, genetics, and molecular biology, she has held various research roles at companies such as Hartzog Lab, Millennium Pharmaceuticals, and Geron Corporation. Dr. Yazar-Klosinski has a proven track record in managing global clinical trials, monitoring clinical trial sites, data management, and compliance with FDA Regulations and ICH/GCP guidelines. She has also published research on RNA binding activity and mentored younger students in a laboratory setting.